AN2 Therapeutics, Inc. ($ANTX)
Prior Stephen David โ Chief Strategy Officer
Shares
2,858
Price
$1.01
Total Value
$2,892.30
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Prior Stephen David |
|---|---|
| Title | Chief Strategy Officer |
| Transaction Date | Jan 6, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Shares Sold | 2,858 |
| Price per Share | $1.01 |
| Total Value | $2,892.30 |
| Shares Owned After | 59,086 |
| Derivative | No |
| Accession Number | 0001193125-26-006770 |
| Document | View SEC Filing |